HTL Stock Overview
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.
Hamilton Thorne Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$1.62|
|52 Week High||CA$2.20|
|52 Week Low||CA$1.31|
|1 Month Change||2.53%|
|3 Month Change||1.89%|
|1 Year Change||-14.74%|
|3 Year Change||54.29%|
|5 Year Change||121.92%|
|Change since IPO||326.32%|
Recent News & Updates
|HTL||CA Medical Equipment||CA Market|
Return vs Industry: HTL exceeded the Canadian Medical Equipment industry which returned -45.2% over the past year.
Return vs Market: HTL underperformed the Canadian Market which returned -7.2% over the past year.
|HTL Average Weekly Movement||4.9%|
|Medical Equipment Industry Average Movement||10.3%|
|Market Average Movement||9.9%|
|10% most volatile stocks in CA Market||18.3%|
|10% least volatile stocks in CA Market||3.8%|
Stable Share Price: HTL is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: HTL's weekly volatility (5%) has been stable over the past year.
About the Company
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand.
Hamilton Thorne Ltd. Fundamentals Summary
|HTL fundamental statistics|
Is HTL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HTL income statement (TTM)|
|Cost of Revenue||US$28.72m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.013|
|Net Profit Margin||3.39%|
How did HTL perform over the long term?See historical performance and comparison